Completed OBSERVATIONAL NCT02063893

Safety Study of Cancer Stem Cell Vaccinie to Treat Breast Cancer (CSC)

Study of Cancer Stem Cell Vcccinie That as a Specific Antigen in Metastatic Adenocarcinoma of the Breast

Sponsor: Fuda Cancer Hospital, Guangzhou

Updated 10 times since 2017 Last updated: Jun 1, 2015 Started: Jan 31, 2014 Primary completion: Jan 31, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Neoplasms, Breast, this trial is completed. The trial is conducted by Fuda Cancer Hospital, Guangzhou and has accumulated 10 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: PHASE1_PHASE2 → None
Aug 2017 — Apr 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Aug 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fuda Cancer Hospital, Guangzhou
University of Michigan

Data source: Fuda Cancer Hospital, Guangzhou

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China